Frontage expanded services provide comprehensive toxicology testing services for our clients, from late discovery through IND preparedness to NDA submissions. Committed to helping Sponsors build confidence in their drugs early, Frontage has integrated safety and toxicology operations between Experimur (Chicago, IL) and Frontage (Concord, OH) and Frontage China, with general toxicology services provided both in the US and China. Newly added assessments include reproductive and developmental toxicology (DART), carcinogenicity assessments, juvenile toxicity testing amongst other specialized toxicology services. Safety Pharmacology is offered at both the Concord and Chicago sites. Cardiovascular and respiratory evaluations are available using the DHI implanted or non-invasive jacketed external telemetry (JET) systems including neurotoxicity testing.
Founder and Former CEO Dr. Song Li, said, “We are continuing to work to develop Frontage into a global CRO of the highest caliber by striving to provide the highest levels of quality, technology and expertise to our clients; and I believe that the addition of Experimur is a major step forward in that effort.”
Nabil Hatoum, Ph.D., D.A.B.T, CEO and Co-founder of Experimur, said, “We are excited to bring our custom-built AAALAC-Accredited, USDA-Registered, 54,000 sq ft. state-of-the-art facility and vivarium to Frontage and we are fully committed to facilitating the integration of Experimur’s operations into the larger impressive Frontage organization.”
About Frontage (www.frontagelab.com)
Frontage Holdings Corp (1521.HK), together with its wholly owned subsidiary Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. For more details, visit: www.frontagelab.com or contact Frontage at sales@frontagelab.com.